UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ

Xekouki, P; Lodge, EJ; Matschke, J; Santambrogio, A; Apps, JR; Sharif, A; Jacques, TS; ... Andoniadou, C; + view all (2019) Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ. Endocrine-Related Cancer , 26 (1) pp. 215-225. 10.1530/ERC-18-0330. Green open access

[thumbnail of Jacques VoR Non-secreting pituitary tumours characterised by enhanced expression of YAP_TAZ.pdf]
Preview
Text
Jacques VoR Non-secreting pituitary tumours characterised by enhanced expression of YAP_TAZ.pdf - Published Version

Download (6MB) | Preview

Abstract

Tumours of the anterior pituitary can manifest from all endocrine cell types but the mechanisms for determining their specification are not known. The Hippo kinase cascade is a crucial signalling pathway regulating growth and cell fate in numerous organs. There is mounting evidence implicating this in tumour formation, where it is emerging as an anti-cancer target. We previously demonstrated activity of the Hippo kinase cascade in the mouse pituitary and nuclear association of its effectors YAP/TAZ with SOX2-expressing pituitary stem cells. Here we sought to investigate whether these components are expressed in the human pituitary and if they are deregulated in human pituitary tumours. Analysis of pathway components by immunofluorescence reveals pathway activity during normal human pituitary development and in the adult gland. Poorly differentiated pituitary tumours (null cell adenomas, adamantinomatous craniopharyngiomas (ΑCPs) and papillary craniopharyngiomas (PCPs)), displayed enhanced expression of pathway effectors YAP/TAZ. In contrast, differentiated adenomas displayed lower or absent levels. Knock-down of the kinase-encoding Lats1 in GH3 rat mammosomatotropinoma cells suppressed Prl and Gh promoter activity following an increase in YAP/TAZ levels. In conclusion, we have demonstrated activity of the Hippo kinase cascade in the human pituitary and association of high YAP/TAZ with repression of the differentiated state both in vitro and in vivo. Characterisation of this pathway in pituitary tumours is of potential prognostic value, opening up putative avenues for treatments.

Type: Article
Title: Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1530/ERC-18-0330
Publisher version: https://doi.org/10.1530/ERC-18-0330
Language: English
Additional information: © 2018 The authors 2018. This article published under a Creative Commons CC BY 4.0 licence (https://creativecommons.org/licenses/by/4.0/deed.en_GB)
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10056626
Downloads since deposit
83Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item